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“Una delle principali cause della miseria delle scienze sta, molto spesso, nella 
loro presunzione di essere ricche. Scopo della scienza non è tanto quello di aprire 
la porta all'infinito sapere, quanto quello di porre una barriera all'infinita 
ignoranza.” 
B. Brecht 
 
“The world is stranger than we can imagine and surprises are inevitable in 
science. Thus we found, for example, that pesticides increase pests, antibiotics 
can create pathogens, agricultural development creates hunger, and flood control 
leads to flooding. But some of these surprises could have been avoided if the 
problems had been posed big enough to accommodate solutions in the context of 
the whole.” 
Richard Levins 
 
“Far better an approximate answer to the right question, which is often vague, 
than an exact answer to the wrong question, which can always be made precise.”  
John Tukey  
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1. OVERVIEW 
Immune and nervous system have been traditionally considered separately, but 
from ‘90s many studies had unraveled the deep interconnection and 
interdependence between these two systems, enough to coin the term 
“neuroimmune system” to define this relationship. 
While it was well known that central nervous system (CNS) actively 
communicates with the immune system to control immune responses both 
centrally and peripherally, the opposite action was just recently discovered. 
Related to the role of immune system in defending and react, the interactions 
between immune system and CNS have been classically studied in contexts of 
neuroinflammation such as trauma, injury and disease [1] [2].  
Recent evidences about the neuroinflammatory process in non-pathological 
conditions and the discovery of the important involvement of adaptive immune 
system in healthy brain development and activity [3], have opened many 
questions about physiological neuroimmune cross-talk. 
In this view, the cytokine network, well known to operate in a bidirectional way 
affecting both immune and nervous system, has a pivotal role in neuroimmune 
cross-talk [4]. Traditionally seen as immunomodulators, in the last years has been 
evident that cytokines are also potent neuromodulators [5]. 
In the complex cytokine system, interleukin 15 (IL-15) is considered a bridge 
between adaptive and innate immune system and it is one of the first upregulated 
cytokines in neuroinflammation [6]. It has many bioregulatory roles which range 
from those of modulator of selected adaptive immune responses [7] [8] and 
central player in the development and homeostasis of several immunocyte 
populations [9] to those of a potent, general inhibitor of apoptosis in multiple 
systems [9]. 
Interestingly, has been shown that IL-15 and IL-15Rα deletions affect memory 
and neurotransmitters concentration suggesting a major role of this signalling in 
cerebral functions which cannot be compensated during the development [10] [11] 
[12]. IL-15Rα KO mice, in particular, show decreased retention of spatial memory 
and contextual fear, both related to hippocampus-dependent memory, and 
alteration in GABA concentration. Their hippocampal ultrastructure is, however, 
well preserved, suggesting that the modulatory changes may involve neural 
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plasticity even if the exact role of IL15 in modulating neurotransmission has not 
been investigated so far. 
The understandings about the mechanism by which IL-15/IL-15Rα system affect 
the synaptic transmission may be useful to get insight into the mechanisms of 
cross talk between the immune and the nervous system and eventually to develop 
strategies to treat pathologies whose symptoms are memory impairments and 
neuroinflammation. 
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2. INTRODUCTION 
2.1 Neuroimmune system 
2.1.1 Composition and interactions 
In recent years it has become clear that there is an extensive cross-talk between 
the nervous and the immune system, so that the term “neuroimmune system” has 
been coined to indicate all the biochemical, electrophysiological and cellular 
structures belonging to both nervous and immune system [17]. This cross-talk 
takes place in different organs, involving a wide range of cells and mediators, 
coordinated through sensory and effector pathways [13]. 
In mammals, this system involves reciprocal regulation which works in two 
directions in both physiological and pathological conditions: the immune-
mediated regulation of nervous system function and the nervous system-
mediated regulation of immunity (Figure 1). Both kinds of interactions are 
mediated by complex mechanisms in which participate the same groups of cells 
and the same kind of molecules [4] and occur both centrally and peripherally [4]. 
If in the past cytokines were considered as the mediators of immune cells and 
neurotransmitters as the mediators of nervous system cells, currently it is known 
that immune system cells can also communicate through neurotransmitters and 
that, viceversa, brain cell populations can communicate each other through 
cytokines. Evidences from the last decade have shown that both the systems are 
able both to sense and produce these molecules. 
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Figure 1. Neurotransmitters and cytokines mediate bidirectional cross-talk between immune and nervous 
cells. This inter-systemic communication may occur in both directions: the regulation of immune cells by 
nervous-derived molecules as well as the modulation of nervous cells by immune-derived molecules. [4] 
Traditionally, neuroimmunology research has been mostly focused on interactions 
in the context of diseases, injuries or traumas but starting from studies on the role 
of microglia in brain development, many researches have shed light on the 
involvement of immune cells in normal CNS function [14]. It was shown, indeed, 
that mechanisms reminiscent of neuroinflammation, such as the involvement of 
complement components and microglia in synapse pruning, also occur in healthy 
brain development [3]. To date, however, the mechanism and the regulation of the 
physiological cross-talk occurring in the neuroimmune system is still almost 
obscure. 
The most common and studied interaction between immune system and CNS is 
the neuroinflammation whose concept has widened years by years up to include 
the response of the reactive CNS elements to altered homeostasis due to infections 
and other causes of cell death, as well as infiltration of the brain and spinal cord 
by cells of the innate and adaptive immune systems [15]. It characterizes almost 
every neurological disease, from developmental ones to traumatic ones passing 
through neoplastic and neurodegenerative diseases. Recent research has 
established a significant role for the immune system in several brain diseases 
including mental disorders further implicating dependent interrelationships 
between the immune system and the brain. 
Any alterations in tissue homeostasis begin a tissue response by CNS-resident 
cells that involves mediators associated with the immune system. In these 
conditions glial cell responses, usually mediated by astrocytes and microglia, 
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include the elevated production of an array of cytokines. Conversely, in chronic 
inflammatory diseases or in acute infectious diseases leukocytes that invade the 
CNS are a major source of inflammatory mediators, including cytokines. If from a 
theoretical point of view we can distinguish between diseases in which cytokines 
are produced predominantly by CNS-resident cells (like during 
neurodegeneration) and disorders where cytokines are delivered by CNS-invading 
leukocytes (like in encephalitides and inflammatory demyelinating disorders), 
actually, many of the cytokines implicated in driving the pathology associated 
with neurodegeneration are also key players in neuroinflammation mediated by 
invading leukocytes like IL‑12, IL‑23 [16], IL‑6 and IL‑1β [17] [18]. 
 
2.1.2 Microglia as one of the main actors on the neuroimmune 
stage 
Microglial cells are the main regulators of both innate and adaptative immune 
response in the CNS. They are the only resident macrophages of CNS under 
steady-state conditions and constitute the first defence line of the immune system 
against any trauma, disease or injury. Their distribution is widespread but there 
are region dependent differences for what concern the density, phenotype and 
responsiveness [19]. 
Since relatively recent years microglia in healthy condition have been considered 
“resting” believed functionally turned off, due to the low expression of 
activation-associated molecules and their apparently immobile ramified 
morphology characterised by thin cellular processes branching off from a small 
soma. In the “activated” state, the microglial cells assume an amoeboid shape, 
enlarging the soma and shortening the processes [14] and is able to modulate 
several molecules to trigger the inflammatory process. 
Nevertheless, it is now well ascertained that microglia is actually very active in its 
“resting” state, constantly monitoring the extracellular space and participating in 
many physiological processes – from synaptic modelling to scavenging of cellular 
debris and secretion of trophic factors - thanks to its thin branches [20]. In this 
state microglial cells are very reactive and can go in the activated state very 
quickly, changing some receptors expression and releasing a broad spectrum of 
inflammatory and immunoregulatory compounds (e.g., neurotoxins, cytokines, 
ROS). 
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Focusing on synapses, it has been revealed that microglia interact with neurons 
directly contacting axonal terminals, dendritic spines, or synaptic clefts and 
eliminate some of them depending on changes in neuronal activity and sensory 
experience, both in the developing and mature brain [21] [22]. Moreover, has 
been demonstrated that disruption of communication between neurons and 
microglial cells through CX3CL1/CX3CR1 signalling leads to defective synaptic 
maturation in hippocampus probably due to a transient reduction in microglia 
surveillance and a consequent reduction of synaptic pruning [3]. 
At the same time a variety of neurotransmitter receptors and transporters are 
expressed on microglia and help mediate the bidirectional communication 
between neurons and microglia. Presumably, the information about the neuronal 
state given through neurotransmitters release is sensed by microglia which, in 
turn, influences neuronal viability in positive and negative feedback loops [22]. 
Electrophyisiological recordings in microglial cells from acute brain slices and in 
culture have shown, for instance, that GABAB-Rs agonists triggered the induction 
of outwardly K+ conductance and attenuate the LPS-induced release of microglial 
cytokines such as IL-6 and IL-12p40 [22]. 
 
2.2 The cytokines system: a common language between immune 
and brain cells 
2.2.1 The huge world of cytokines 
The term ‘cytokines’ derives from the fusion of two Greek words 
cyto, "κύτος, kytos" which means “cavity, cell" and kines, "κίνησις, kinēsis" which 
means “movement". It identifies a group of small (~5-20kDa) soluble peptides 
and pleiotropic proteins released by immune cells, representing key regulators of 
the prototypical innate and adaptive immune response to infection. Their 
pleiotropic nature by which a given cytokine can induce differential, even 
opposite responses in different cell types, makes the cytokine network very 
complex [23]. Moreover, cytokines can cross-talk with signalling from other 
soluble factors in a time-, concentration- and tissue-specific manner. 
The cytokine family is very wide (over 300 cytokines were discover up to date) 
and includes interferons (IFNs), interleukins (ILs), chemokines, mesenchymal 
growth factors, the platelet derived growth factors (PDGF), transforming growth 
factors (TGF), the tumor necrosis factors family (TNFs) and adipokines classified 
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depending on the nature of the immune response, with individual cytokines also 
performing specific roles dependent upon cell type and location. Usually the 
cytokines were distinguished pro- and anti-inflammatory but numerous evidences 
showed that this classification is too simplicistic and that a given cytokine may 
behave as a pro- or anti-inflammatory one depending on the cytokine amount, the 
nature of the target cell, the nature of the activating signal, the timing, the 
sequence of cytokine action and even the experimental model. 
 
2.2.2 Cytokines and synaptic plasticity 
Cytokine levels in nervous tissue are relatively low in physiological conditions 
(≤1 pg in 1 ml or mg) but they rapidly increase after various CNS or PNS injuries, 
seizures or infection [5]. Nevertheless, it is clear that cytokine networks in the 
brain are fundamental for the dynamics and the communications between neurons, 
glia, endothelial and immune cells acting in complex paracrine and autocrine 
ways. It seems that a controlled and timely production of cytokines is required for 
normal tissue function. Beyond their recognized role in neuroinflammation, they 
are involved in several aspects of normal CNS activities: they participate in the 
regulation of sleep [24], in neuronal development [25] [26] [27], in 
neuroendocrine functions and in ageing. 
The major sources of cytokine synthesis and release in the CNS is the glia 
(microglia and astrocytes), although blood-imported cytokines may contribute to 
tissue level changes. Excessive levels of cytokines can, in turn, promote both glia 
and BBB dysfunction, with an impact on neuronal cell excitability and viability. 
Neurons may release cytokines too, particularly during the acute injury phase 
underlying neuronal damage [28]. Anyway, inflammatory pathways may be 
activated even in the absence of pathogens - the so-called sterile inflammation - 
because of changes in the extracellular ionic milieu. In this situation cytokines and 
related effector molecules can act both in autocrine or paracrine manner inducing 
different signalling pathways depending on the target cell. 
With respect to neurons, cytokines have profound effects upon synaptic plasticity, 
especially in the hippocampus [29] [30], and many electrophysiological studies 
have demonstrated a modulation of neuronal activity by a wide variety of 
cytokines [31] [32] [33] [34]. This modulation can occur either indirectly by 
promoting the release of neuroactive molecules from glia or the endothelium (e.g, 
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nitric oxide, glutamate, prostaglandins, neurotrophins), or directly by activating 
their neuronal receptors in the brain and spinal cord [35] [36] [37]. 
The direct activation of neuronal cytokine receptors rapidly alters their excitability 
via post-translational modifications of either voltage-gated or receptor-coupled 
ion channels, and by promoting presynaptic changes in neurotransmission (Figure 
2). These alterations are very rapid in their onset (seconds/minutes) but they 
persist for very long time in vivo (hours/weeks) [38]. 
 
Figure 2. Several cytokines have been recognized as modulators of synaptic transmission [5]. 
Cytokines have been found to modulate neuronal properties at both pre- and post-
synaptic levels. Effects of cytokines on voltage-gated channels (VGCs) as on 
receptor operated ion channels (ROCs) have been reported. Some cytokines affect 
only excitatory or inhibitory transmission, but several others behave in more 
complex ways acting differently depending on neuronal type, brain region or dose 
[5]. 
Given that activation of peripheral inflammatory responses has been associated 
with mood and anxiety disorders and that peripheral immune activation can 
spread to the CNS, there has been great interest in the impact of cytokines and 
their signalling  pathways on neurotransmitter systems known to be associated 
with depression and anxiety including serotonin, norepinephrine, dopamine and 
glutamate [39]. There is less knowledge about the effects of inflammatory 
cytokines on other neurotransmitter systems in the brain that play a role in 
depression and anxiety like GABA and acetylcholine. Nevertheless, there is 
emerging data regarding interactions between inflammatory cytokines and these 
neurotransmitter systems that may have profound consequences for immune 
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regulation. For example, studies in rodents have indicated that GABA can reduce 
the release of inflammatory cytokines through inhibition of NF-kB and p38 
MAPK signalling pathways [40] and decrease the progression of experimental 
autoimmune encephalomyelitis, an animal model of MS [41]. Interestingly, CSF 
from MS patients with enhanced brain lesions inhibited GABA transmission in 
mouse brain slices, an effect that could be blocked with an IL-1-beta, antagonist 
[41]. These findings indicate that inflammation in the CNS may decrease 
GABAergic tone, which could further trigger inflammatory cytokine production. 
Taken together, these findings indicate that a potential decrease in release of 
GABA in the brain in response to inflammatory cytokines may promote 
inflammatory responses [42]. 
Finally, recent studies demonstrated that the CXCL16 chemokine can modulate, 
through A3 receptor and microglial cells, both inhibitory and excitatory synaptic 
transmission in CA1 area increasing the frequency of the miniature inhibitory 
synaptic currents (mIPSCs) and the paired-pulse ratio (PPR) of evoked IPSCs 
(eIPSCs), suggesting a presynaptic modulation of the probability of GABA 
release [43]. 
 
2.3 Interleukin 15 (IL-15) 
2.3.1 IL-15/IL-15Rα system and signalling transduction 
More than 60 cytokines are classified as interleukins and are named by interleukin 
number. The name "interleukin" was chosen in 1979 during the Second 
International Lymphokine Workshop in Switzerland and derives from (inter-) "as 
a means of communication", and (-leukin) deriving from the fact that many of 
these proteins were first seen to be produced by leukocytes and act on leukocytes. 
Actually, the name is a residue because has been found that interleukins are 
produced by a wide variety of body cells.  
Among cytokines, interleukin-15 (IL-15) was discovered in 1994 by its ability to 
mimic IL-2–mediated T-cell proliferation but it is now well established that it is 
produced even by many nonimmune cells both in basal conditions and in response 
to viral infections, LPS, and other signals that trigger innate immunity. It is, in 
fact, a pleiotropic cytokine of the 4-a-helix bundle cytokine family that includes 
not only cytokines such ad IL-2 but also growth factors and classical hormones, 
including human growth hormone and prolactin. 
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The importance of this interleukin is suggested by the finding that it is well 
conserved among different species, exhibiting 73% of identity between human 
and murine forms. 
There are two alternatively spliced mRNA products which account for the 
existence of two distinct IL-15 isoforms, which differ only in the length of their 
signal peptide [9]. The two isoforms can be translated in an IL-15 precursor 
protein with a 48-aa long signal peptide (IL-15LSP) and a in a precursor IL-15 
protein with a 21-aa short signal peptide (IL-15SSP). In both human and mouse, 
both alternative transcripts produce a mature IL-15 protein that differs only in the 
sequence of the signal peptide (Figure 3). IL-15SSP is not secreted, but rather 
stored intracellularly in the cytoplasm while IL-15LSP is found in the Golgi, early 
endosomes and the ER, possibly leading to cytokine secretion [44]. IL-15 protein 
is a member of the four a-helix bundle cytokine family characterized by 
antiparallel juxtaposed helices A, C, B, D, and 2 long end-to-end loops, loops AB 
and CD, which are connected by a short b-sheet packed against helices Band D. In 
the secondary structure there are two disulphide bonds at positions 42Cys–88Cys 
and 35Cys–85Cys. The C terminus of IL-15 also contains two sites for N-linked 
glycosylation.  
 
Figure 3. Schematic diagram of IL-15 and IL-15Ra genes. (A) IL-15 gene consists of nine exons and eight 
introns located on human chromosome 4q31 and mouse chromosome 8. Two isoforms of IL-15 containing 
short (21-aa) or long (48-aa) signal peptide (IL-15SSP and IL-15LSP, respectively) exist. Alternative exon 4a 
in human corresponds to exon 5A in the mouse IL-15 gene. (B) IL-15Ra gene consists of seven exons, and 
many protein isoforms were described as a result of an alternative splicing mechanism in both human and 
mice [6]. 
The IL-15 receptor (IL-15R) consists of 3 subunits, IL-15Rα chain, IL-2Rβ chain 
(CD122), and the common γc (CD132). The IL-15Rα subunit is unique to IL-15 
but it is incapable of signalling alone. IL-2Rβ is also a receptor for IL-2, and the 
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common γc is shared by IL-2, IL-4, IL-7, IL-9, and IL-21. Unlike the IL-2Rα, IL-
15Rα consists of 1 sushi domain which are used for ligand binding. 
The IL-15/IL-15R system modulates functions of almost all cell populations of 
immune system and it is very important for their development and homeostasis. 
Interestingly, IL-15 is recognized as a major modulator of many different types of 
non-immune cells (Figure 4). 
 
Figure 4. Functional properties of IL-15. Schematic diagram of the IL-15-mediated effects in different non-
immune cell types [9]. 
This is one of the most important functional difference with IL-2, whose functions 
are almost exclusively restricted to T cells. IL-15 mRNA is found to be highly 
expressed in mesenchymal stem cells and their differentiated cell types, including 
osteoblasts, adipocytes, endothelial cells and myoblasts. Finally, studies on fetal 
human brain showed IL-15 and IL-15Rα mRNA expressions in the cerebral 
cortex, cerebellum, hippocampus, medulla, and thalamus [19] and human cell 
cultures express IL-15 mRNA in microglia, astrocytes, and neuronal cell lines 
[20]. In the mouse brain, instead, IL-15Rα transcripts are present since P6, while 
IL-15 mRNA appears in hippocampal formation only since P20 [21]. 
The role of IL-15 in non-immune tissues is still largely unexplored. 
 
2.3.2 Signal transduction of IL-15 signalling 
IL-15 functions through different mechanisms: the trans-presentation mechanism 
which is contact-dependent and consists in the presentation of the membrane-
bound IL-15/IL-15Rα complex to responding cells that express IL-2/IL-15Rβ-γc 
complex [45]; the cis-presentation mechanism which is less common and consists 
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in the presentation of the membrane-bound IL-15/IL-15Rα complex to IL-2/IL-
15Rβ-γc complex present on the same cell surface; the binding of soluble IL-
15/IL-15Rα complex to IL-2/IL-15Rβ-γc complex (Figure 5). 
In vivo, IL-15 is believed to exist mainly in a complex with IL-15Rα, this could 
explain why the trans-presentation is the main mechanism of transduction [46]. 
 
Figure 5. The mode of interaction of interleukin-2 and interleukin-15 with the subunits of their receptors. 
Interleukin-2 (IL-2) is a secreted cytokine that binds pre-formed high-affinity heterotrimeric receptors that 
comprise the IL-2 receptor α-chain (IL-2Rα), IL-2/15Rβ and the common cytokine-receptor γ-chain (γc). By 
contrast, IL-15 is a membrane-associated molecule that induces signalling at the immunological synapse 
between antigen-presenting cells and natural killer (NK) cells or CD8+ T cells. IL-15Rα on the surface of 
monocytes or dendritic cells presents IL-15 in trans to cells that express IL-2/15Rβ and γc alone, thereby 
allowing signalling through these complexes. The mode of interaction of interleukin-2 [46]. 
In T lymphocytes, IL-15, binding to its complex receptor system, initiates a 
cytosolic signal cascade which induces tyrosine phosphorylation of the Janus 
Kinase (JNKs) family members JAK-1 and JAK-3 and subsequently downstream 
activation of the transcription factors STAT-3 and STAT-5. Phosphorylated 
STATs do form homodimers, translocate in the nucleus and regulate transcription 
factors. 
In mast cells, IL-15 utilises another receptor called IL-15RX and activates a 
distinct signalling pathway involving JAK-2 and STAT-5. 
It is clearly demonstrated that JAK/STAT pathway is one of the most important 
signalling pathways involved in the regulation of neural function and that its 
dysregulation in brain pathologies both in human and animal models. It is 
involved in leptin-induced neuroprotection and in the control of food intake [47], 
Alzheimer's disease and memory [48].  
Finally, it is known that JAK can regulate the expression or function of several 
neurotransmitter receptors, including NMDA, AMPA and GABA receptors [49]. 
These evidences suggest that IL-15 system may affect neurotransmission through 
its JAK/STAT effector pathway. 
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2.3.3 The IL-15/IL-15Rα system and behaviour 
Beyond its recognized role in inflammation and diseases, several researches have 
recently investigated the ability of IL-15/IL-15Rα to affect behaviour. To this 
purpose, IL-15 and IL-15Rα KO mice have been generated. They both have a 
significant reduction of the peripheral and thymic NK cells, Natural Killer T 
(NKT), intestinal intraepithelial lymphocytes and CD8+ memory T cells which 
makes them more susceptible to fatal infections with microorganisms that are 
normally not lethal [46]. Nevertheless, the two different interruptions of IL-15 
signalling result in different mouse phenotypes proving unique roles for IL-15Rα 
and IL-15 in vivo [50]. 
IL-15Rα KO mouse shows significant reduced anxiety in the “open field test” and 
in the “elevated plus maze test” while IL-15 KO and IL-2Rγ KO mice showed 
much milder changes, indicating that deficiency of a cytokine ligand or shared 
receptor can be partially compensated by pleiotropic cytokine pathways [10]. 
According to evidences from in vitro studies which demonstrate a modulation of 
the IL-15 during muscle function and dysfunction, the global IL-15Rα KO mice 
have greater cage activity during both the light and dark spans and resistance to 
fatigue due to a remodelling of fast skeletal muscles to a slower and more 
oxidative phenotype [51]. This behaviour seems to depend on the effect of IL-
15Rα signalling on the hypothalamus which lead to excessive motor activation, 
disrupted circadian rhythm of thermoregulation, and altered metabolic phenotype 
[52]. This phenotype is not recapitulated by muscle-specific deficiency of IL-
15Rα [53] but it is likely that it is due to an anxious state related to hippocampal 
functionality [12]. Hippocampus-specific IL-15Rα KO mice, in fact, show a 
greater peripheral locomotor activity [22] – thigmotaxis, validated as a measure of 
anxiogenic behaviour [54].  
These evidences and the demonstration of abundance of IL-15 and its specific 
receptor in the hippocampus [55], suggest a role of IL-15/IL-15Rα signalling in 
hippocampal-dependent memory even due to its recognized involvement in 
hippocampal neurogenesis [56] [57]. 
The effect of the signalling seems limited to a specific part of memory because 
IL-15Rα KO mice do not have any problems in memory acquisition while show 
deficits in memory retention in the ”Stone T-maze test”, with a significant 
augment of errors [11]. Moreover, trained in “fear conditioning test”, the IL-
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15Rα KO mice show the same freezing response to tone conditioning suggesting 
intact emotional memory but freezing to the preceding contextual fear 
conditioning is significantly reduced, indicating impaired contextual memory 
[10]. Since hippocampal activity is required for early consolidation of fear 
conditioning with a short trace interval [58] [59] [60], it is likely that the 
hippocampus is a major structural component mediating the memory deficits of 
the IL-15Rα knockout mice. 
 
2.4 Hippocampal memory and GABAergic system 
2.4.1 The hippocampal connectivity 
The hippocampus, in the temporal lobe, is phylogenetically one of the oldest parts 
of the brain and forms part of the limbic system. It is one of the most studied 
region of the brain thanks to its relatively simple circuitation, its high plasticity 
and its well-recognized role in learning and memory. This plasticity is both 
structural and functional. For each hippocampal cell type, in fact, the size and 
complexity of the dendritic trees as well as the size, shape, and number of 
dendritic spines can change, and substantial adult neurogenesis has been 
demonstrated in the dentate gyrus [61]. 
The hippocampus properly said is defined by the dentate gyrus (DG) and Cornu 
Ammonis (CA) (Figure 6). While the dentate gyrus contains the fascia dentata 
and the hilus, the CA is anatomically and functionally differentiated into distinct 
subfields named CA1, CA2 and CA3. 
The hippocampal cortex has a three-layered appearance. The first layer is a deep 
layer, comprising a mixture of afferent and efferent fibres and interneurons. In the 
DG this layer is represented by the hilus, whereas in the CA regions it is referred 
to as the stratum oriens. More superficially there is the cell layer, which is 
composed of principal cells and interneurons. In the DG this layer is called the 
granule layer, whereas in the CA regions it is referred to as the pyramidal cell 
layer (stratum pyramidale). The most superficial layer is called the molecular 
layer (stratum moleculare) in the DG while in the CA region it is subdivided in 
many sublayers. In CA3, three sublayers are distinguished: the stratum lucidum, 
which receives input from the DG; the stratum radiatum, comprising the apical 
dendrites of the neurons located in the stratum pyramidale; and, most 
superficially, the stratum lacunosum-moleculare, comprising the apical dendrites. 
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The lamination in CA2 and CA1 is similar, with the exception that the stratum 
lucidum is not present. 
 
Figure 6. picture of hippocampal circuit. The main hippocampal inputs arrive through Entorhinal Cortex 
(EC) to dentate gyrus. The granule cells of DG project to CA3 pyramidal neurons which, in turn, make 
synapses with CA1 neurons. 
Most of the hippocampus’s neocortical inputs come from the perirhinal and 
parahippocampal cortices, through the entorhinal cortex, and most of its 
neocortical output is through the subiculum, which also projects back to the 
entorhinal cortex. 
The hippocampus has an elongated and curved form which is conserved across all 
mammalian orders. It expands along a dorsal (septal)-to-ventral (temporal) axis in 
rodents corresponding to a posterior-to‑anterior axis in humans but the intrinsic 
circuitry is maintained throughout the long axis. Despite this conserved intrinsic 
circuitry, the dorsal and ventral portions have different connectivity with cortical 
and subcortical areas which lead to different functions. 
It was proposed that the more ventral parts of the hippocampus mediate emotional 
responses [62] because there is denser ventral than dorsal connectivity with the 
amygdala [63] [64] and hypothalamic endocrine and autonomic nuclei [65]. The 
dorsal parts of the hippocampus seem to mediate cognitive functions, particularly 
memory [66]. Rodents with hippocampal lesions exhibit impairments in different 
kind of memories from spatial to object recognition memory [67]. 
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3. AIM OF THE STUDY 
It has long been apparent that the immune system and the brain are closely 
connected and that they interact in a bidirectional way but the mechanism by 
which this communication occurs are still poor known. The interleukin IL-15 
system is considered one of the key pathways linking innate and acquired 
immunity and it is known to be constitutively expressed in human neural cell lines 
and tissues [55]. In addition, deletion of IL-15/IL-15Rα system affect 
hippocampal-dependent memory suggesting a role for IL15 in the regulation of 
synaptic transmission at the hippocampal level. 
The aim of my PhD research project was to investigate how the synaptic 
transmission in hippocampal area was affected by modulation of IL-15/IL-15Rα 
system to disclose the mechanisms behind the cross-talk between the immune and 
the nervous system. 
  
To this purpose I used both in vivo and ex vivo experimental approaches including 
electrophysiological recordings and behavioural tests, to evaluate: 
 
• alterations in hippocampal synaptic transmission associated with deletion 
of IL-15/IL-15Rα signalling; 
• behavioural phenotype of IL-15Rα KO mouse through the NOR task 
known to be related to hippocampal-dependent memory [68];  
• the effects on synaptic transmission of in vivo delivery of IL-15 or IL15 
application in acute slices. 
Microglia represents the resident immune cell population of the brain, being one 
of the major sources of IL-15 in the CNS. Moreover, in previous works has been 
observed that IL-15Rα KO mice have hippocampal microgliosis [10]. 
In the attempt to get insights about the cellular pathways associated to IL-15-
mediated regulation of neuronal function, I also evaluate the microglial alterations 
in IL-15Rα mice. 
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4. MATERIALS AND METHODS 
4.1 Animals 
Procedures using laboratory animals were in accordance with the Italian and 
European guidelines and were approved by the Italian Ministry of Health in 
accordance with the guidelines on the ethical use of animals from the European 
Communities Council Directive of September 20, 2010 (2010/63/UE). All efforts 
were made to minimize suffering and number of animals used. 
Wild type (WT) C57BL/6J and B6;129X1-IL-15ratm1Ama/J (IL-15Rα KO) mice 
were used for electrophysiological recordings of synaptic currents and microglia 
isolation and data were confirmed on IL-15Rα+/+, IL-15Rα+/- and IL-15Rα-/- 
littermates mice. For IL-15 treatment of brain slices and IL-15 brain delivery with 
osmotic pumps, adult C57BL/6J (WT) mice were used. All experiments were 
performed on adult male mice (6-8 post-natal weeks). 
 
4.2 Genotyping DNA extracted from mouse tail 
IL-15Rα-/- mice were mated with C57BL/6J to obtain heterozygous IL-15Rα+/- 
mice. These heterozygous mice, in turn, were mated between them to obtain 
heterozygous IL-15Rα+/- and homozygous IL-15Rα+/+ and IL-15Rα-/- littermates 
mice. The offspring was genotyped by the polymerase chain reaction (PCR). For 
genotyping, PCR was used to amplify targeted regions from the IL-15Rα+/+, IL-
15Rα+/- and IL-15Rα-/- gene allelesFigure 1 (Figure 7). 
 
Figure 7. Results of PCR performed on DNA extracted from tail snips obtained in-blind from IL-15Rα+/-
mice offspring. The double band represents the IL-15Rα+/- allele, the lower band is IL-15Rα+/+ allele and the 
higher band is IL-15Rα-/- allele. 
Genomic DNA was extracted from tail snips (1 cm) obtained in-blind from 
anesthetized adult male mice before performing in-blind electrophysiological 
experiments and DNA was extracted through a chloroform/ethanol DNA 
extraction protocol. PCR reactions were performed using a 25 μl total reaction 
volume containing 1 μM each of forward and reverse primers, 0.2 mM each of 
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dNTP, 2 mM magnissium chloride, 1.5 U Taq DNA polymerase and 0.1 μg 
genomic DNA with a thermal cycler (iCycler, Bio-Rad). The cycling parameters 
were as follows: hot start 95 °C (2 min); denaturing 94 °C (30 s); annealing 58 °C 
(30 s); extension 72 °C (45 s) with final extension step of 7 min. Thirty-two cycles 
were used for these experiments. These are primer sequences used to identify the 
different genotypes: 
Gene Forward 5’—3’ Reverse 5’—3’ 
IL-15Rα +/+ 
(171 bp) 
 
ATTGAGCATGCTGACATCCG 
 
ACTGATGCACTTGAGGCTGG 
IL-15Rα -/- 
(280 bp) 
 
CTTGGGTGGAGAGGCTATTC 
 
AGGTGAGATGACAGGAGATC 
 
4.3 Patch clamp recordings of CA1 pyramidal neurons from ex 
vivo hippocampal brain slices 
For electrophysiological recordings of GABAergic and glutamatergic 
transmission at CA3-CA1 synapses, acute hippocampal slices were obtained from 
6-8 weeks old mice. Animals were decapitated under halothane anaesthesia. 
Whole brains were rapidly removed from the skull and immersed in ice-cold 
artificial cerebrospinal fluid (ACSF) solution containing (in mM): 87 NaCl, 75 
Sucrose, 2 KCl, 7 MgCl2, 0.5 CaCl2, 25 NaHCO3, 1.2 NaH2PO4 and 10 glucose, 
pH 7.3, 300–305 mOsm. The ACSF was continuously oxygenated with 95% O2 
and 5% CO2 to maintain the physiological pH. Trasversal 300 μm thick slices 
were cut at 4°C using a Vibratome (ThermoScientific HM 650 V) and placed in a 
chamber filled with oxygenated ACSF containing (in mM): 125 NaCl, 2 KCl, 1.2 
MgCl2, 2 CaCl2, 25 NaHCO3, 1.2 NaH2PO4 and 10 glucose, pH 7.3, 300–305 
mOms. Before use, brain slices were allowed to recover at least for 1 h before 
recording at room temperature, then transferred to a recording chamber within 1–6 
h after slice preparation. All recordings were performed at room temperature on 
slices submerged in ACSF and perfused with the same solution in the recording 
chamber at a rate of approximately 2 ml/min by using a gravity-driven perfusion 
system.  
Spontaneous (sIPSCs, sEPSCs), miniature (mIPSCs, mEPSCs) and evoked 
postsynaptic currents (eIPSCs, eEPSCs) were recorded from CA1 pyramidal 
neurons using the patch clamp technique in whole-cell configuration, which 
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allowed to record currents through multiple channels simultaneously, over the 
membrane of the entire cell. Patch clamp recordings were performed by using a 
Multiclamp 700B amplifier (Molecular Devices, USA). Signals were acquired 
(sampling 10 kHz, low-pass filtered 2 kHz) with DigiData-1440A using 
pCLAMP-v10 software (Molecular Devices, USA); the analysis was performed 
off-line using Clampfit 10 (Molecular Devices) and MiniAnalysis (Mini Analysis, 
Synaptosoft Fort Lee, NJ, USA). Cell capacitance was constantly monitored over 
the time and experiments were access resistance changed more than 20% were 
discarded. 
Glass electrodes (3–5 MΩ) were pulled with a vertical puller (PC-10, Narishige). 
Pipette were filled with 148 mM Cs Methanesulfonate, 10 mM Hepes, 0.5 mM 
EGTA, and 2 mM Mg-ATP, Na3-GTP 0.3 mM, MgCl2 2 mM (295–300 mOsm, 
pH 7.2). 
GABAergic outward membrane currents were recorded with the neuron clamped 
at 0 mV. At this voltage, Cl− mediated inhibitory events are outward currents 
(estimated ECl = − 80 mV) whereas excitatory currents are inward but of small 
amplitude as they would occur close to their reversal potential. Although it was 
possible to isolate sIPSCs pharmacologically, by using 20 μM DNQX plus 10 μM 
AP-5 to block both the AMPA and NMDA receptor components of spontaneous 
excitatory postsynaptic currents (sEPSCs), this antagonist mixture sometimes 
attenuated or occasionally completely blocked sIPSCs. This presumably reflected 
impediment of excitatory synaptic drive to the inhibitory interneurons that were 
responsible for sIPSC generation. In view of this variable effect of DNQX/AP-5 
on sIPSCs, we elected to use a holding potential of 0 mV rather than 
pharmacological methods to separate sIPSCs from sEPSCs. The validity of this 
approach is supported by the observation that 100μM picrotoxin (PTX) 
completely eliminated all spontaneous outward current activity recorded at 0 mV 
(data not shown). 
Miniature EPSCs/IPSCs were recorded during an initial 10 min baseline period, 
followed by application of TTX (0.5μM, Tocris Bioscience, Bristol, United 
Kingdom) for 10 min. After stabilization of TTX effect, exogenous IL-15 (10nM, 
PeproTech EC Ltd., London, UK) was applied for 10 min. Only data from the last 
5 min of each recording epoch was analyzed to ensure that drugs had fully 
equilibrated. 
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By using the same conditions, excitatory post-synaptic currents (EPSCs) were 
recorded clamping the cell at − 70 mV. In a subset of experiments, the 
glutamatergic nature of the mEPSC recordings was confirmed at the end of the 
experiment by total blockade of mEPSCs by DNQX (20 μM; data not shown). 
For evoked post-synaptic currents, paired-pulse protocol and input/output curve, 
to equilibrate Cl- reversal potential at -70 mV, we used the following Cl- adjusted 
intracellular solution (in mM) with an addition of QX314 to block voltage-
activated Na+ channels: Cs-methanesulfonate 125, CsCl 17.5, HEPES 10, EGTA 
0.2, NaCl 8, MgATP 2, NaGTP 0.3, QX314-Br 2 (pH adjusted to 7.3 with CsOH). 
A concentric bipolar stimulating electrode (SNE-100 × 50 mm long Elektronik-
Harvard Apparatus GmbH, Crisel Instruments, Rome, Italy) was positioned in the 
stratum radiatum to evoke eIPCSs from CA1 pyramidal neurons. Pairs of stimuli 
(ISI 25, 50, 100 and 700ms) were applied every 20 sec. Stimulus intensity was of 
amplitude about 50% of maximal amplitude, delivered through a A320R Isostim 
Stimulator/Isolator (WPI). Paired Pulse Ratio (PPR) was calculated as the ratio 
between the amplitude evoked by the second stimulus (A2) over the first (A1; 
A2/A1) and the amplitude of each EPSC/IPSC was measured relative to a 2 ms 
long baseline period starting 3 ms before stimulation. To measure the amplitude 
of the second peak the baseline was adjusted to zero. The stimulus intensity was 
adjusted accordingly to the experiment. 
For input/output curves, inhibitory fibers were stimulated at increasing intensities 
(0.1-10 mA). Each pulse of a given intensity was repeated 6 or more times to 
obtain an average response. 
 
4.4 Extracellular field recordings of CA3-CA1 circuit from ex 
vivo hippocampal brain slices 
For field recordings, individual hippocampal slices (350 μm) were transferred to 
the interface slice-recording chamber (BSC1, Scientific System Design Inc) to 
perform experiments within 1–6 h after slice preparation. Slices were maintained 
at 30 to 32 °C and constantly superfused with ACSF at the rate of 2 ml/min.  
Solutions were applied to the slices by a peristaltic pump. A concentric bipolar 
stimulating electrode (SNE-100 × 50 mm long, Elektronik–Harvard Apparatus 
GmbH) was placed in the stratum radiatum to stimulate Schaffer collateral fibers. 
Stimuli consisted of 100 μs constant current pulses of variable intensity, applied at 
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0.05 Hz. A glass micropipette (0.5–1 MΩ) filled with ACSF was placed in the 
CA1 hippocampal region, at 200–600 μm from the stimulating electrode, in order 
to measure orthodromically-evoked field extracellular postsynaptic potentials 
(fEPSP). Stimulus intensity was adjusted to evoke fEPSPs of amplitude about 
50% of maximal amplitude with minimal contamination by a population spike. 
Evoked responses were monitored online and stable baseline responses were 
recorded for at least 10 min. Only the slices that showed stable fEPSP amplitudes 
were included in the experiments. LTP was induced by high-frequency 
stimulation (HFS, 1 train of stimuli at 100 Hz of 1 s duration). To analyze the time 
course of fEPSP amplitude, the recorded fEPSP was routinely averaged over 1 
min (n = 3). fEPSP amplitude changes following the LTP induction protocol were 
calculated with respect to the baseline. 
The paired-pulse ratio (PPR) was measured from responses to two synaptic 
stimuli at 50 ms inter-stimulus interval. The PPR was calculated as the ratio 
between the fEPSP amplitude evoked by the second stimulus (A2) over the first 
(A1; A2/A1).  
fEPSPs were recorded and filtered (low pass at 1 kHz) with an Axopatch 200 A 
amplifier (Axon Instruments, CA) and digitized at 10 kHz with an A/D converter 
(Digidata 1322 A, Axon Instruments). Data acquisition was stored on a computer 
using pClamp 9 software (Axon Instruments) and analyzed off-line with Clampfit 
10 program (Axon Instruments). 
 
4.5 Isolation of CD11bþ cells and extraction of total RNA 
Brains of IL-15Rα KO or WT mice were cut into small pieces and single-cell 
suspension was achieved by enzymatic digestion in trypsin (0.25 mg mL-1), in 
Hank’s balanced salt solution (HBSS) and mechanical dissociation using a wide-
tipped pipette. Cell suspension was applied to a 30-mm cell strainer and 
immediately processed for MACS Micro Bead separation. The CD11bþ cells were 
magnetically labelled with CD11b Micro Beads. The cell suspension was loaded 
on a MACS Column (Miltenyi Biotec) placed in the magnetic field of a MACS 
Separator and a negative fraction was collected. After removing the magnetic 
field, CD11bþ cells were eluted as positive fraction. Vitality and purity of 
CD11bþ cells were assessed using flow cytometry (FACS). On sorting the 
positive and negative fractions, total RNA was isolated with the RNeasy Mini Kit 
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and processed for RT–PCR. The quality and yield of RNAs were verified with 
Ultraspec2000 UV/Visible (Pharmacia Biotech). 
 
4.6 RT–PCR 
Samples were lysed in Trizol reagent for isolation of RNA. Reverse transcription 
reaction was performed in a thermocycler using IScript TM RT Supermix (Bio-
Rad) under the following conditions: incubation, 25°C, 5min; reverse 
transcription, 42°C, 30 min; inactivation, 85°C, 5min. RT–PCR was carried out in 
a I-Cycler IQ Multicolor RT–PCR Detection System using SsoFast EvaGreen 
Supermix (Bio-Rad). The PCR protocol consisted of 40 cycles at 95°C, 30 s and 
at 60°C, 30 s. For quantitative analysis the comparative Threshold Cycle (Ct) 
method was used, while normalizing to Ct value of GAPDH in the same sample. 
Relative quantification was performed using the 2-ΔΔCt method [68] and expressed 
as fold changes in arbitrary values. 
Primers used are the following ones: 
Gene Forward 5’—3’ Reverse 3’—5’ 
gapdh TCGTCCCGTAGACAAAATGG TTGAGGTCAATGAAGGGGTC 
arg1 CTCCAAGCCAAAGTCCTTAGAG AGGAGCTGTCATTAGGGACATC 
fizz CCAATCCAGCTAACTATCCCTCC ACCCAGTAGCAGTCATCCCA 
ym1 CAGGTCTGGCAATTCTTCTGAA GTCTTGCTCATGTGTGTAAGTGA 
inos ACATCGACCCGTCCACAGTAT CAGAGGGGTAGGCTTGTCTC 
il1b GCAACTGTTCCTGAACTCAA TATCTTTTGGGGTCCGTCAA 
tnfa GTGGAACTGGCAGAAG GCCATAGAACTGATGAGA 
bdnf TGAGTCTCCAGGACAGCAAA TGTCCGTGGACGTTTACTTCT 
gat2 GGGTATTACATCGGGCA ACACCCCGGATCAGAA 
gabbr2 AGCAAGCGTTCGGGTGTA TGGCGTTGAGGATGATTCT 
abat ACACTAAATCCAACGAGC AAGGGCGGAGACTATG 
 
4.7 IL-15 delivery in hippocampus of WT mice with micro-
osmotic pumps 
Eight-week-old male C57BL/6J mice were anaesthetized with chloralhydrate (400 
mg kg-1, i.p.), placed in a stereotaxic head frame and implanted with an osmotic 
pump in the right hippocampus (AP +2.3mm, ML +1.75mm, DV –1.75mm 
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according to the atlas). A cannula was implanted through a hole and was sealed 
with dental cement before connecting to the pump. The pump was placed into a 
subcutaneous pocket in the dorsal region. The pumps were filled up with vehicle 
(PBS) or IL-15 (133 ng mL-1). Before surgery, the pumps and the tubes were 
incubated at 37°C overnight in a sterile saline. The experiment continued for 7 
days after the pump implantation. IL-15 doses were selected considering the ex 
vivo experiments. 
 
4.8 Novel object recognition (NOR) 
If mice are presented familiar and novel objects, they will explore more the novel 
objects. This typical behavior was exploited to evaluate recognition memory 
linked to hippocampus [69]. Experimentally naïve, littermate, age-matched, 
maleWTand IL-15Rα KO mice, were subjected to the test. 
The NOR task protocol lasts 3 days (Figure 8).  
 
Figure 8. Picture of the three phases of NOR task. In the habituation phase the animal can freely explore 
the box for 10 minutes in absence of any stimulus. In the sample phase the animal can explore two copies of 
the same object A for 10 minutes. In the test phase, 1 or 24 hour later, the animal can explore the familiar 
object A or the novel object B for 5 minutes. 
A total of three objects of different colours were used for the experiments. They 
were made of plastic or glazed ceramic and there were two copies of each object. 
All objects were sufficiently heavy so that they could not to be displaced by the 
mice. The role (familiar or novel) as well as the relative position of the two 
stimulus objects were counterbalanced and randomly permuted for each 
experimental animal. The open field arena and the stimulus objects were cleaned 
thoroughly between trials to ensure the absence of olfactory cues. 
The test arena was a square, gray wooden box (40 × 40 × 40 cm). In the test room 
a camera was suspended from the ceiling directly above the center of the arena 
and was connected to a computer, located in an adjacent room, which used 
Ethovision XT (Noldus) to record the trials. 
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In the first day (habituation phase), all the animals were habituated to the open 
field arena by allowing them to freely explore it 10 min in the absence of stimulus 
objects. This procedure was used to reduce the possibility of context exploration 
interfering with object exploration 
On day 2 (sample phase), mice were placed in the open field containing two 
identical objects and left to freely explore them for 10 min. The test phase was 
performed either 60 min (to analyze short-term memory or STM) or 24 h after the 
sample phase (to evaluate long-term memory or LTM). In the test phase one of 
the objects was randomly replaced with a novel object and mice were 
reintroduced into the open field for an additional 5-min period. 
Exploration was defined as entering with the nose and/or forepaws in a defined 
square surrounding the stimulus object (when the animal is at a distance of less 
than 2cm from the object). The time spent exploring each object was scored by an 
observer who was blind with respect to the genotype of the animal and the object 
allocation during the test trial (i.e., familiar or novel). The exploration was 
expressed as a percentage of the total exploration time in seconds and all test trials 
were scored for the whole 5-min duration. Student’s t-test was used to analyze the 
data. 
Discrimination Index (DI) was computed through the following formula where EB 
and EA represent the exploration time of the novel and familiar object 
respectively:  
𝐷𝐼 =
(𝐸𝐵 − 𝐸𝐴)
(𝐸𝐵 + 𝐸𝐴)
 
 
 
4.9 Statistical analysis 
All data are presented as mean ± SEM. Origin 6 and Origin 8 (OriginLab 
Corporation, Northampton, Massachusetts, USA) softwares were used for 
statistical analysis of electrophysiological data. Statistical significances were 
determined by paired and unpaired t-test, one-way and two-way ANOVA, 
Kolmogorov-Smirnov test as indicated. P values less than 0.05 were considered 
significant. Levels of significance were set as *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 
0.001. In the legend, the number of cells and the number of animals are expressed 
together in the form n.cells/n.animals (i.e. 15/5 means 15 cells/5 animals).  
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5. RESULTS 
5.1 IL-15Rα KO mice show altered inhibitory synaptic 
transmission in CA1 hippocampal neurons. 
To investigate the alterations in synaptic transmission associated with deletion of 
IL-15/IL-15 Rα pathway, I recorded glutamatergic and GABAergic transmission 
in CA1 pyramidal neurons from acute hippocampal slices obtained from WT and 
IL-15Rα-/- mice (6th-8th postnatal week). I performed in-blind experiments on IL-
15Rα+/+, IL-15Rα-/- littermates. Since IL-15Rα+/+ and WT mice showed the same 
electrophysiological properties, for further experiments WT mice were used as 
controls (Figure 9). 
 
Figure 9. Post-synaptic currents recorded in CA1 pyramidal neurons obtained from C57BL/6J (WT) and 
IL-15Rα+/+ mice show comparable properties. The two genotypes are similar thus for some experiments 
C57BL/6J mice were used as controls of IL-15Rα-/- mice. 
Whole-cells recordings of excitatory and inhibitory postsynaptic currents were 
performed at -70 mV and +0 mV respectively (with an intracellular solution of 
CsMetSO3), and both the frequency and the amplitude of synaptic events were 
analyzed. 
The recordings of spontaneous activity showed no differences in both spontaneous 
excitatory (sEPSCs) and inhibitory (sIPSCs) transmission between WT and IL-
15Rα KO mice (ANOVA One-way, Figure 10). The analysis of rise and decay 
times showed that there were not changes in the kinetics of synaptic events (data 
not shown). 
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Figure 10. IL-15Rα KO mice show normal spontaneous synaptic activity in CA1 neurons. Spontaneous 
excitatory and inhibitory post-synaptic currents recorded in CA1 hippocampal neurons of IL-15Rα KO (n = 
10/5) and WT (n = 8/6) mice. The mean values were computed analysing 5 minutes of stable recording at -70 
mV and at 0 mV, respectively. For sIPSCs recording DNQX and AP-5 were added to bath solution to block 
glutamatergic transmission. A) No significant differences were found in sEPSCs between the two genotypes 
neither in frequency (left; WT = 1.35 ± 0.29Hz, KO = 2.41 ± 0.87Hz) or amplitude (right; WT = 10.00 ± 
0.57pA; KO = 11.49 ± 0.84pA). B) Spontaneous inhibitory activity is not different in IL-15Rα KO (n = 12/4) 
and in WT mice (n = 9/3) regarding both frequency (left; WT = 3.63 ± 0.44Hz, KO = 4.76 ± 0.70Hz) and 
amplitude (right; WT = 15.73 ± 1.01pA, KO = 16.10 ± 1.44pA). 
To investigate whether differences in synaptic transmission between WT and IL-
15Rα KO mice were masked by the occurrence of action potential, I added TTX 
(a blocker of voltage gated sodium channels) to the bath solution and recorded 
miniature post-synaptic currents (mIPSCs and mEPSCs). In that condition I 
observed that the frequency of mIPCSs recorded in hippocampal slices obtained 
from IL-15Rα-/- mice was statistically increased compared to WT mice (p=0.034, 
one-way ANOVA; Figure 11D).  By contrast the mIPSCs amplitude was identical 
between the two genotypes (p=0.77, one-way ANOVA; Figure 11E) suggesting a 
presynaptic alteration of the release probability of GABA at this synapse rather 
than modification of post-synaptic receptors, more associated with amplitude 
changes. 
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Figure 11. The frequency of mIPSCs in CA1 pyramidal neurons is significantly increased in IL-15Rα-/- 
mice.  A, B) Post-synaptic currents of CA1 pyramidal neurons were recorded in whole-cell patch clamp 
configuration. The recordings were made from acute hippocampal slices obtained from IL-15Rα+/+ (n = 13/4) 
and IL-15Rα-/- mice (n = 8/2). C) Representative mIPSCs recordings of hippocampal neurons of the two 
different genotypes. D) Normalized cumulative probability curve of inter event interval (IEI) (calculated on 2 
minutes recording for each cell) was significantly shifted towards the left for IL-15Rα-/- compared to IL-
15Rα+/+ (Kolmogorov-Smirnov test, p=0.049).(inset; mean mIPSCs frequency IL-15Rα-+/+ = 3.48 ± 0.37Hz, 
IL-15Rα-/- = 4.68 ± 0.45Hz, p=0.034). E) Normalized cumulative probability of mIPSCs amplitudes. The 
mean amplitude of mIPSCs is not affected by the different genotype (inset; IL-15Rα-+/+ = 15.60 ± 0.52pA, IL-
15Rα-/- = 15.29 ± 0.37pA, p=0.77).  
As observed for the sEPSCs, no differences were found in glutamatergic mEPSCs 
frequency or amplitude between the two genotypes (p>0.05, one-way ANOVA; 
Figure 12). These results showed that IL-15Rα deletion altered only GABAergic 
transmission, possibly through a presynaptic mechanism. 
 
Figure 12. Recordings of mEPSCs do not show any significant differences between IL-15Rα-+/+ and IL-
15Rα-/- mice. A) Representative recordings of mEPSCs of CA1 neurons from acute hippocampal slices 
obtained from IL-15Rα-+/+ (n = 15/4) and IL-15Rα-/- mice (n = 5/2). The means were computed on 5 minutes 
recordings. B) The mean amplitude of mIPSCs is not affected by the different genotype (inset; IL-15Rα-+/+ = 
9.36 ± 0.21pA, IL-15Rα-/- = 9.12 ± 0.25pA). C) The mean frequency calculated of mIPSCs was not 
significantly different between IL-15Rα-+/+ and IL-15Rα-/- (IL-15Rα-+/+ = 0.50 ± 0.07Hz, IL-15Rα-/- = 0.41 ± 
0.03Hz; p=0.48). 
5.2 IL-15Rα KO mice show increased GABA release in CA1 
area 
To deep investigated alterations in the probability of GABA release at inhibitory 
synapses I recorded the evoked inhibitory postsynaptic currents (eIPSCs) in CA1 
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pyramidal neurons by using a paired-pulse protocol to stimulate inhibitory 
presynaptic fibers in the stratum radiatum (Figure 13). 
 
Figure 13. Electrical stimulation of Schaffer collaterals and recordings from CA1 pyramidal neuron. A) 
Anatomical location of acute hippocampal slices. B) Placement of the patch pipette in cornu ammonis 1 
(CA1) and stimulating electrode on stratum radiatum; Schaeffer collaterals (SC); dentate gyrus (DG); cornu 
ammonis 3 (CA3). C) Paired Pulse Ratio calculation. 
The paired pulse ratio (i.e. the ratio between the second and the first pulse, PPR) 
is related to Pr (the probability of neurotransmitter release). Synapses with low 
value of Pr show paired pulse facilitation (PPF) in paired stimulation protocol. 
This is widely held to be due to residual Ca2+ in the presynaptic terminal from the 
first action potential adding to the Ca2+ influx from the second pulse [70] [71]. 
The larger presynaptic Ca2+ leads to facilitated or increased neurotransmitter 
release on the second ‘pulse’ or action potential. By contrast, inhibitory synapses 
usually show paired pulse depression (PPD), with the first peak bigger than the 
second. PPD relies on the activation of presynaptic GABAB receptors and tends to 
peak at 100-300 ms [72] [73]. I found that in IL-15Rα KO the paired pulse ratio 
was significantly lower at inter-stimulus interval (ISI) of 25, 50 and 100 ms and it 
came back to control values at 700ms ISI (25ms p=0.019, 50ms p=0.048, 100ms 
p=0.057, 700ms p=0.33; one-way ANOVA; Figure 14B). These results confirm 
that IL-15Rα KO mice have a higher probability of GABA release in CA1 
hippocampal area. 
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Figure 14. Paired pulse ratio measured at different inter stimulus intervals. A) Representative recordings of 
PPD at ISI = 50 ms in WT and IL-15Rα KO mice. B) At shorter ISIs there is a significant reduction of mean 
PPR in IL-15Rα KO mice (13/4) compared to WT (14/5) (25ms ISI: WT = 0.58 ± 0.04, KO = 0.42 ± 0.04; 
p=0.019, ;  50ms ISI: WT = 0.76 ± 0.04, KO = 0.55 ± 0.03; p=0.048) At ISI = 100 ms there is a reduction of 
PPR in IL-15Rα KO which is at the limits of significance (WT = 0.79 ± 0.05, KO = 0.66 ± 0.04; p=0.057) 
whereas at 700 ms PPR values were not different (WT = 0.82 ± 0.06, KO= 0.73 ± 0.06; p=0.33). 
To investigate whether the increased GABA neurotransmission is due to increased 
inhibitory connectivity I also analysed the input output curve (I/O curve) by 
measuring the amplitude of eIPSCs elicited by stimuli of graded intensities. The 
inhibitory post-synaptic currents increased similarly in the two genotypes at 
increasing stimulation intensity (Figure 15), suggesting that the strength of 
inhibitory input onto CA1 pyramidal neurons is not affected by the lack of IL-
15/IL-15Rα signalling. 
 
Figure 15. The strength of inhibitory input onto CA1 pyramidal neurons is similar between WT and IL-
15Rα KO mice. The normalized I/O curve of IPSCs recorded in CA1 neurons of WT (n = 8/3) and IL-15Rα 
KO mice (n = 12/5) is similar in the two genotypes. 
 
5.3 IL-15Rα KO mice show normal CA3-CA1 glutamatergic 
transmission with no alterations in short- (STP) and long-term 
potentiation (LTP) 
Since the IL-15Rα KO mice show memory impairments REF, I investigated the 
hippocampal plasticity through experiments of STP and LTP induction in CA3-
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CA1 circuit. Extracellular field recordings (fEPSP) of glutamatergic transmission 
in hippocampal brain slices obtained from IL-15Rα KO and WT mice were 
performed (Figure 16A). The short-term potentiation and the long-term 
potentiation were similar in WT and IL-15Rα KO mice (Figure 16B). 
This finding agrees with the results on sEPSCs and mEPSCs, suggesting that the 
effect of IL-15/15Rα signalling disruption is confined to the inhibitory system. 
 
Figure 16. Extracellular field recording of excitatory transmission in CA3-CA1 circuit show no differences 
between IL-15Rα+/+ and IL-15Rα-/- mice. A) Picture of stimulation and recording electrodes position on 
hippocampal slice to record fEPSPs. B) LTP was induced by a high frequency stimulation protocol (HFS, 1 
train of stimuli at 100 Hz of 1 s duration) in hippocampal slices obtained from IL-15Rα+/+ (n = 6/4) and IL-
15Rα-/- mice (n = 5/2). C) PPR was measured from responses to two stimuli at 50ms inter-stimulus interval 
and was calculated as the ratio between the fEPSP amplitude evoked by the second stimulus over the first. 
 
5.4 IL-15Rα KO mice are impaired in Novel Object Recognition 
(NOR) task 
To evaluate whether the alterations in hippocampal synaptic transmission 
observed in the electrophysiological recordings were correlated to a behavioural 
deficit, the mice have been subjected to the “novel object recognition task” 
(NOR). We have choosen this test because it is the best-known task to assesses 
recognition memory and has been shown that hippocampus, mainly the dorsal 
region, is essential for NOR memory formation and for object recognition [69].  
Results show that IL-15Rα KO mice have a significant lower discrimination index 
in both the short-term memory (STM, 1h after sample phase) and long-term 
memory (LTM, 24h after sample phase) tests compared to controls (Figure 17). 
This evidence agrees with previous behavioural data [11] [10] [12] and with our 
findings that IL-15/IL-15Rα system affects hippocampal functionality.  
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Figure 17. IL-15Rα KO mice are impaired in novel object recognition test. IL-15Rα KO mice (n = 5) 
showed a significant lower Discrimination Index (DI) compared to WT mice (n = 5) both 1 hour after sample 
phase (Short-Term Memory or STM, WT DI = 0.38 ± 0.09, KO DI = 0.15 ± 0.04, p=0.046, t-test) and 24 
hours after sample phase (Long-Term Memory or LTM, WT DI = 0.22 ± 0.09, KO DI = -0.38 ± 0.21, 
p=0.045, t-test). 
5.5 Microglia extracted from hippocampi of IL-15Rα KO mice 
show an altered mRNA expression 
IL15 and IL-15Rα are expressed by several cell populations in the brain ranging 
from immune cells to glia and neuronal cells. In order to shed light on the cellular 
pathways associated to IL-15-mediated regulation of neuronal function I focused 
on microglia since these cells are the only resident macrophages of CNS and 
previous studies have shown that IL-15Rα KO mice have mild microgliosis 
[50].At first I investigated the phenotype of microglial cells isolated from the 
hippocampi of IL-15Rα KO and WT mice performing RT-PCR to analyse the 
expression level of some inflammatory genes such as inos, TNFα, IL-1β, ym-1, 
arg-1, fizz-1. The results showed that microglia cells from IL-15Rα KO mice do 
not have different levels of expression compared to WT mice. Not surprisingly, 
iNOS was found to be down regulated in KO mice (p=0.049, t-test), as already 
described following the IL-15 signalling blockade [74]. This result suggests that 
the absence of IL-15/IL-15Rα signalling does not affect the state of activation of 
microglia (Figure 18).  
 
Figure 18. mRNA expression levels of inflammatory genes in hippocampal microglial cells isolated from 
IL-15Rα KO and WT mice. Microglia isolated from IL-15Rα KO does not show a specific anti- or pro-
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inflammatory profile. Among the studied genes only iNOS expression is significantly reduced in KO mice 
compared to WT. Tnfα WT = 1 ± 0.2, KO = 0.55 ± 0.15; Inos WT = 1 ± 0.10, KO 0.46 ± 0.12, p = 0.049; Il1β 
WT = 1 ± 0.02, KO = 2.7 ± 0.9; Ym-1 WT = 1 ± 0.1, KO = 2.2 ± 1.13; Arg-1 WT = 1 ± 0.24, KO = 1.91 ± 
1.34; Fizz-1 WT = 1 ± 0.23, KO = 0.50 ± 0.09. 
I also analyzed BDNF mRNA expression because recent studies demonstrated 
that there is a direct link between BDNF levels and IL-15 release in microglia 
which can, in turn, modulate immune response in CNS [75] [76]. Interestingly, the 
microglia of IL-15Rα KO mice showed a significant increase of BDNF mRNA 
levels compared to WT mice (WT = 5; IL-15Rα KO = 5, p = 0.005, t-test, Figure 
19). This evidence may indicate a role of BDNF released by microglial cells 
which is known to modulate inhibitory transmission [77] [78] and to be necessary 
in multiple learning tasks [79]. 
 
Figure 19. BDNF mRNA expression level is significantly increased in microglia isolated from 
hippocampus of IL-15R KO mice. Microglia isolated from hippocampus of KO mice (n = 7) shows a 
significant increase in the expression level of BDNF mRNA compared to controls (n = 6). WT = 1.00 ± 0.40, 
KO = 6.90 ± 2.00, p = 0.005, t-test. 
Since He et al. showed that GABA concentration of hippocampus homogenates of 
IL-15Rα KO mice is significantly reduced compared to controls and that IL-15 
directly modulates GABA turnover in a dose-response relationship [8], I 
wondered whether microglia may participate in this GABA dysregulation through 
a modulation of genes belonging to the GABAergic machinery. Microglial cells 
are considered, in fact, GABAceptive cells because they are not able to synthetize 
GABA transmitter, but they are able to sense and respond to it [80]. They express 
mRNA and proteins of transporters (GAT-2), metabolism (GABA-T or ABAT) 
and receptors (GABAA-R and GABAB-R) which are modulated by many factors 
such as milieu conditions, inflammatory status or activation status of microglia 
[81] [80] (Figure 20A). 
The mRNA expression level of all the genes linked to GABAergic system are 
significantly increased in IL-15Rα KO mice compared to WT mice (Figure 20B). 
These findings suggest that microglia may concur to the emergence of the 
behavioural phenotype of IL-15Rα KO mice and may indicate a direct 
involvement of microglia in the modulation of GABA transmission. 
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Figure 20. Hippocampal microglial cells isolated from IL-15Rα KO mice show an altered mRNA 
expression of genes belonging to GABAergic machinery compared to WT mice. A) Microglial cells are 
GABAceptive cells which can respond and modulate GABA signalling. B) All the genes belonging to 
GABAergic system analyzed by RT-PCR were significantly increased in IL-15Rα KO mice (n = 6) compared 
to WT mice (n = 6). GAT-2 WT level = 1.00 ± 0.15, KO level = 7.52 ± 2.2, p = 0.046; GABABR2 WT level = 
1.00 ± 0.10, KO level = 11.25 ± 2.8, p = 0.024; ABAT WT level = 1.00 ± 0.17, KO level = 7.80 ± 2.7, p = 
0.032; t-test. 
5.6 Treatment with exogenous IL-15 affects inhibitory but not 
excitatory synaptic transmission in the hippocampus 
Since knocking down genes in a constitutive manner can lead to compensatory 
mechanisms, I verify that IL-15 delivery modulated inhibitory synaptic 
transmission in WT mice.  
We recorded inhibitory post-synaptic currents from CA1 pyramidal neurons 
before and after the exogenous IL-15 application (10nM, 10 minutes) on acute 
hippocampal slices obtained from WT adult mice. The IL-15 treatment 
significantly increased the mIPSCs frequency without altering mIPSCs amplitude 
(p=0.01, paired t-test, Figure 21) suggesting that even the acute treatment of IL-
15 affects the inhibitory neurotransmission at the presynaptic level. 
 
Figure 21. The frequency of mIPSCs in CA1 neurons from WT mice is modulated by treatment with 
exogenous IL-15. mIPSCs currents in hippocampal neurons from WT mice were recorded before and after 
treatment with IL-15 (n = 6). The means were computed on 2 minutes recordings. A) The upper graph 
represents the mean frequency of mIPSCs, the bottom graph represents the mean amplitude of mIPSCs. Only 
the frequency is affected by IL-15 application (p=0.01). B) Timecourse of IL-15 treatment effect on mIPSC of 
a representative neuron. The upper graph represents the mean inter event interval (IEI) of one minute-
recording and the bottom graph represents the mean amplitude of one minute recording. The bottom inset 
represents the access resistance of the cell. 
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To understand whether IL-15 can modulate hippocampal synaptic transmission in 
physiological conditions, micro osmotic pumps charged with IL-15 10nM or 
vehicle were implanted in right hippocampus of WT adult mice (Figure 22A). 
After 7 days of chronic delivery, hippocampal slices were obtained from these 
animals and whole-cell recordings of mIPSCs of pyramidal neurons were 
performed. The results show that the chronic treatment increases the frequency of 
mIPSCs (One-way ANOVA, p=0.042) similarly to what observed with acute IL15 
directly on slices (Figure 22B, C). 
 
Figure 22. Delivery of IL-15 in hippocampus of WT mice alters the frequency of inhibitory synaptic 
transmission. A) Micro osmotic pumps were implanted in right hippocampus of adult WT mice and vehicle 
(water, n = 13/3, SHAM) or IL-15  (133ng/mL, n = 9/3) was chronically delivered for one week. mIPSCs of 
CA1 neurons of these animals were recorded and analyzed. B) The mean amplitude of mIPSCs was not 
significantly different between SHAM and IL-15-treated mice (SHAM = 15.97 ± 0.67pA, IL-15 = 17.43 ± 
1.21pA; p=0.27). C) The frequency of mIPSC in animals treated with IL-15 was significantly higher 
compared to SHAM animals (SHAM = 3.22 ± 0.27Hz, IL-15 = 6.99 ± 2.07; p=0.042). 
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6. DISCUSSION 
The present study shows that CNS-immune system interaction through IL-15/IL-
15Rα system profoundly and specifically influences inhibitory synaptic 
transmission in the hippocampus. The constitutive absence of this signalling leads 
to an increased release probability at synaptic sites which, in turn, can explain 
specific behavioural deficits. Actually, IL-15Rα KO animals show a lower 
discrimination index in the “novel object recognition task” and this impairment 
may be related to alterations in GABAergic synaptic transmission in the 
hippocampus. 
Previous studies have reported that IL-15Rα KO mice have hippocampal-
dependent memory deficits and a reduced GABA concentration in hippocampus 
homogenates [11]. Nevertheless, the hippocampus ultrastructure remained intact 
suggesting that this dysfunction may be related to alterations at synaptic level. In 
this study, I analyzed CA3-CA1 circuit in adult mice reporting that IL-15Rα KO 
mice show an altered synaptic transmission characterised by a higher GABA 
release probability compared to WT mice. This conclusion is based on the 
analysis of several electrophysiological evidences. First, I reported that the 
frequency of action potential independent mIPSCs is higher in CA1 pyramidal 
neurons of IL-15Rα KO mouse compared to WT, suggesting a presynaptic 
alteration. Consistently, the lower paired pulse ratio observed in IL-15Rα KO 
mouse argues for an increase in the probability of GABA transmitter release [82]. 
In addition, the results on the input/output inhibitory curve show that the strength 
of inhibitory transmission is normal in IL-15Rα KO hippocampus probably due to 
increased presynaptic GABA release rather than increased number of inhibitory 
connections/interneurons. 
The synaptic alterations associated to the IL-15Rα deletion seems to be specific 
for the inhibitory neurotransmission given that both spontaneous and evoked 
synaptic excitatory transmission is unaltered between IL-15Rα KO and WT mice. 
I also found that treatment of acute hippocampal slices of adult WT mice with IL-
15 increases the frequency of mIPSCs in a way comparable to that observed in IL-
15Rα KO mice. These are unexpected results because removal of IL-15Rα 
receptor surprisingly produces an increase in neurotransmitter release levels which 
goes in the same direction than acute application of IL-15 on WT mice. However, 
it is described that sometimes deletion of genes in organisms can have paradoxical 
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effects because of the existence of compensatory pathways. Since it has been 
described an elevated concentration of IL-15 in the serum of IL-15Rα KO mice 
[50], it is not possible to exclude that the higher concentrations of IL-15 induces 
signalling through its coreceptors IL-2Rβ and IL-2Rγ resulting in the formation of 
a low affinity ligand-receptor complex. Nevertheless, the behavioural defects and 
presence of gliosis indicate that the role of IL-15Rα predominates. 
Furthermore, the results on the effect of IL-15 delivery in adult WT mice support 
the idea that IL-15/IL-15Rα signalling may have a physiological role in 
modulating neurotransmission. I show for the first time that IL-15 can modulate 
GABAergic transmission in hippocampus and that the absence of the IL-15/IL-
15Rα signalling leads to changes in the presynaptic GABAergic probability of 
release. It is possible that these effects are at least partially due to the action of 
microglia. Indeed, microgliosis has been observed in the brain of IL-15Rα KO 
mouse and I found that hippocampal microglia of these mice show a significant 
increase of mRNA expression of BDNF and genes related to GABAergic system. 
It has been demonstrated that BDNF released by microglial cells can modulate 
inhibitory transmission [77] and mice with a specific microglial deletion of BDNF 
show deficits in multiple learning tasks and a significant reduction in motor 
learning-dependent synapses [79]. It is also known that increase of GABAB 
receptors expression in microglia induces attenuation of microglial cytokines 
secretion. Thus, this increase in receptors in IL-15Rα KO mice may be a 
compensatory effect according to the general protective role of the inhibitory 
GABA neurotransmitter. 
Overall, this study shed light on the importance of the crosstalk between IL-15 
and GABAergic system as language in immune system and brain communication 
at synaptic level and may be useful, in future, to develop strategies to treat 
pathologies whose symptoms are memory impairments and neuroinflammation. 
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